Event Details

XBiotech Inc at the 26th EADV Congress

Thursday, September 14, 2017 2:00 pm CEST
Title
XBiotech Inc at the 26th EADV Congress
Date / Time
Thursday, September 14, 2017 2:00 pm CEST
Location
Geneva, Switzerland
Description
Results of the Randomized Phase 2 Study Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa will be presented.